Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT03335280
Overview
This is a prospective, single center, open-label study in adult patients with presumed World Health Organization (WHO) grade 3 or 4 glioma who will be undergoing surgical resection as standard of care. In some cases, patients will have had biopsy. Study participants will undergo 68Ga-citrate Positron Emission Tomography / magnetic resonance (PET/MR) prior to surgery.
Sponsor
University of California, San Francisco
Contacts
Susan Chang, MD (PRINCIPAL_INVESTIGATOR)
ClinicalTrials.gov
NCT03335280Drug / Compound
Eligibility
Help us improve your experience